Stereotactic body radiation therapy for liver metastases

European Journal of Cancer

Volumn 45, Issue 17, 2009, Pages 2947-2959

  Dawood, Omar ^a   Mahadevan, Anand ^b   Goodman, Karyn A ^c  

^a ACCURAY INCORPORATED   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colorectal neoplasms; Liver; Neoplasm metastasis; Radiosurgery

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; GAMMA GLUTAMYLTRANSFERASE;

ADJUVANT THERAPY; ANOREXIA; ARTHRALGIA; ARTICLE; ASTHENIA; BILE DUCT FISTULA; BILE LEAKAGE; BLOOD CLOTTING DISORDER; BLOOD TOXICITY; BREATH HOLDING; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILL; CLINICAL EFFECTIVENESS; COLON PERFORATION; CRYOABLATION; DIARRHEA; DOSIMETRY; FATIGUE; FEVER; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HEART INFARCTION; HEMORRHAGIC GASTRITIS; HICCUP; HUMAN; HYPOTENSION; INTESTINE PERFORATION; KIDNEY FAILURE; LIVER ABSCESS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER HEMORRHAGE; LIVER METASTASIS; LIVER PARENCHYMA; LIVER RESECTION; LUNG EMBOLISM; LUNG INFECTION; MALAISE; MELENA; MULTIMODALITY CANCER THERAPY; MYOGLOBINURIA; NAUSEA; NEUROPATHY; OVERALL SURVIVAL; PAIN; PATIENT POSITIONING; PATIENT SELECTION; PLEURA EFFUSION; PNEUMONIA; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED EMESIS; RADIOFREQUENCY ABLATION; REOPERATION; SKIN TOXICITY; STEREOTACTIC BODY RADIATION THERAPY; STOMATITIS; SURGICAL MORTALITY; SURGICAL TECHNOLOGY; TREATMENT OUTCOME;

DOSE FRACTIONATION; HUMANS; LIVER NEOPLASMS; MOTION; PATIENT SELECTION; RADIOMETRY; RADIOSURGERY; RESPIRATION; TREATMENT OUTCOME;

EID: 70350576874     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.011     Document Type: Article

References (63)

1. Grover A., and Alexander Jr. H.R. The past decade of experience with isolated hepatic perfusion. Oncologist 9 6 (2004) 653-664
2. Mazzaglia P.J., Berber E., and Siperstein A.E. Radiofrequency thermal ablation of metastatic neuroendocrine tumors in the liver. Curr Treat Options Oncol 8 4 (2007) 322-330
3. Bojalian M.O., Machado G.R., Swensen R., and Reeves M.E. Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review. Gynecol Oncol 93 2 (2004) 557-560
4. Kemeny N. Management of liver metastases from colorectal cancer. Oncology (Williston Park) 20 10 (2006) 1161-1176 1179; discussion 1179-80, 1185-6.
5. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 1 (2007) 43-66
6. Small R., Lubezky N., and Ben-Haim M. Current controversies in the surgical management of colorectal cancer metastases to the liver. Isr Med Assoc J 9 10 (2007) 742-747
7. Poston G.J., Adam R., Alberts S., et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23 28 (2005) 7125-7134
8. Lochan R., White S.A., and Manas D.M. Liver resection for colorectal liver metastasis. Surg Oncol 16 1 (2007) 33-45
9. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 6 (2002) 759-766
10. Portier G., Elias D., Bouche O., et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24 31 (2006) 4976-4982
11. Kelly H., and Goldberg R.M. Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 23 20 (2005) 4553-4560
12. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 4 (2004) 644-657 discussion 657-8.
13. Garrean S., Hering J., Saied A., Helton W.S., and Espat N.J. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195 4 (2008) 508-520
14. Vogl T.J., Zangos S., Eichler K., Yakoub D., and Nabil M. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol 17 4 (2007) 1025-1034
15. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221 1 (2001) 159-166
16. Weiss L., Grundmann E., Torhorst J., Hartveit F., Moberg I., Eder M., et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150 3 (1986) 195-203
17. Wagner J.S., Adson M.A., Van Heerden J.A., Adson M.H., and Ilstrup D.M. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199 5 (1984) 502-508
18. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 5 (1995) 1237-1248
19. Austin-Seymour M.M., Chen G.T., Castro J.R., et al. Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys 12 1 (1986) 31-35
20. Russell A.H., Clyde C., Wasserman T.H., Turner S.S., and Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 27 1 (1993) 117-123
21. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
22. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 1 (1991) 109-122
23. Dawson L.A., Ten Haken R.K., and Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 11 3 (2001) 240-246
24. Borgelt B.B., Gelber R., Brady L.W., Griffin T., and Hendrickson F.R. The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 7 5 (1981) 587-591
25. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 4 (1992) 781-788
26. Leibel S.A., Pajak T.F., Massullo V., et al. A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 13 7 (1987) 1057-1064
27. Jackson A., Ten Haken R.K., Robertson J.M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31 4 (1995) 883-891
28. Leksell L. Stereotactic radiosurgery in trigeminal neuralgia. Acta Chir Scand 137 (1971) 311-314
29. Lax I., Blomgren H., Naslund I., and Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33 6 (1994) 677-683
30. Blomgren H., Lax I., Naslund I., and Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34 6 (1995) 861-870
31. Hamilton A.J., Lulu B.A., Fosmire H., Stea B., and Cassady J.R. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 36 2 (1995) 311-319
32. Murray B., Forster K., and Timmerman R. Frame-based immobilization and targeting for stereotactic body radiation therapy. Med Dosim 32 2 (2007) 86-91
33. Heinzerling J.H., Anderson J.F., Papiez L., et al. Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys 70 5 (2008) 1571-1578
34. Eccles C., Brock K.K., Bissonnette J.P., Hawkins M., and Dawson L.A. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys 64 3 (2006) 751-759
35. Guckenberger M., Krieger T., Richter A., et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol (2008)
36. Wurm R.E., Gum F., Erbel S., et al. Image guided respiratory gated hypofractionated stereotactic body radiation therapy (H-SBRT) for liver and lung tumors: initial experience. Acta Oncol 45 7 (2006) 881-889
37. Korreman S.S., Juhler-Nottrup T., and Boyer A.L. Respiratory gated beam delivery cannot facilitate margin reduction, unless combined with respiratory correlated image guidance. Radiother Oncol 86 1 (2008) 61-68
38. Nioutsikou E., Seppenwoolde Y., Symonds-Tayler J.R., et al. Dosimetric investigation of lung tumor motion compensation with a robotic respiratory tracking system: an experimental study. Med Phys 35 4 (2008) 1232-1240
39. Seppenwoolde Y., Berbeco R.I., et al. Accuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: a simulation study. Med Phys 34 7 (2007) 2774-2784
40. Andrews D.W., Bednarz G., Evans J.J., and Downes B. A review of 3 current radiosurgery systems. Surg Neurol 66 6 (2006) 559-564
41. Wulf J., Hadinger U., Oppitz U., et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 12 (2001) 645-655
42. Goodman K.A. Stereotactic radiosurgery for liver malignancies using the CyberKnife. In: Urschel Jr. H.C. (Ed). Treating tumors that move with respiration (2007), Springer, Heidelburg 217-225
43. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15 4 (2005) 279-283
44. Dawson L.A., Eccles C., and Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45 7 (2006) 856-864
45. Tse R.V., Hawkins M., Lockwood G., et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26 4 (2008) 657-664
46. Mendez Romero A., Wunderink W., Hussain S.M., et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol 45 7 (2006) 831-837
47. Katz A.W., Carey-Sampson M., Muhs A.G., et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 67 3 (2007) 793-798
48. Kavanagh B.D., Schefter T.E., Cardenes H.R., et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45 7 (2006) 848-855
49. Sato M., Uematsu M., Yamamoto F., et al. Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer. J Radiosurg 1 3 (1998) 233-238
50. Blomgren H., Lax I., Goranson H., et al. Radiosurgery for tumors in the body: clinical experience using a new method. J. Radiosurg 1 1 (1998) 63-74
51. Hoyer M., Roed H., Traberg Hansen A., et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45 7 (2006) 823-830
52. Schefter T.E., Kavanagh B.D., Timmerman R.D., et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62 5 (2005) 1371-1378
53. Wada H., Takai Y., Nemoto K., and Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 58 4 (2004) 1114-1120
54. Herfarth K.K., Debus J., Lohr F., et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19 1 (2001) 164-170
55. Herfarth K.K., Hof H., Bahner M.L., et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57 2 (2003) 444-451
56. Goodman KA, Anderson EM, Maturen KE, et al. Dose escallation study of stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys, in press.
57. Khatri V.P., Petrelli N.J., and Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol 23 33 (2005) 8490-8499
58. Fong Y., Blumgart L.H., and Cohen A.M. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin 45 1 (1995) 50-62
59. Elias D., Goharin A., El Otmany A., et al. Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol 26 8 (2000) 763-769
60. Pawlik T.M., Izzo F., Cohen D.S., Morris J.S., and Curley S.A. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 10 9 (2003) 1059-1069
61. de Baere T., Risse O., Kuoch V., et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 181 3 (2003) 695-700
62. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 6 (2004) 818-825 discussion 825-7
63. Thirion P., Michiels S., Pignon J.P., et al. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol 22 18 (2004) 3766-3775